XRB980803

	The European Agency for the Evaluation of Medicinal Products
	Human Medicines Evaluation Unit

London, 3 August, 1998

EMEA-H-RB-mtr-27362-1998

Direct Line +44.171.418.8411

Dear Mr Medawar,

I am writing to you further to your letter of 24 July, 1998.

I can inform you that after adoption, EMEA opinions are forwarded to the European Commission. Once received by the European Commission, an EMEA opinion is subject to a procedure which results in a binding Commission Decision.

The Commission Service which principally administers this procedure in the Pharmaceuticals Products and Cosmetics Unit of Directorate General III.

I would suggest that you contact directly Mr Patrick Deboyser, Head of Unit (Tel.++32.2.295.41.28 - Fax++32.2.296.15.20)

I hope this information is helpful.

Yours sincerely

Rolf Bass

Head of Human Medicines Evaluation Unit

----------------------------------

Social Audit Ltd

P O Box 111 London NW1 8XG

Telephone/Fax 44 (0)171 586 7771

4 August 1998

Dear Professor Bass,

Thanks for your fax and for telling me that the CPMP/EMEA opinion has been forwarded to the Pharmaceutical Products and Cosmetics Unit of DGIII

I will get in touch with M Deboyser as you suggest. Thank you for this helpful information.

Yours sincerely,

Charles Medawar

CLICK HERE TO READ ON

Contents page

Correspondence with government